Metastatik Renal Hücreli Kanserde Hedefe Yönelik İlaçları Nasıl Kullanalım?

Cilt: 37 Sayı: 3 1 Eylül 2011
  • Nilüfer Avcı
  • Osman Manavoğlu
PDF İndir
EN TR

How To Use Targeted Drugs in Metastatic Renal Cell Cancer

Öz

In Renal cell cancer biology (RCC), with vascular endothelial growth factor and diagnosing of mammalian target of rapamycin B pathway, new options (targeted drugs) are developed in therapy. With Targeted Drugs, new period started now in the RCC treatment which has limited treatment option at one time. Then bevasizumab, temsirolimus, everolimus and pazopanib were added to workings that initially started with sunitinib and sorafenib. Although antitumoral effects of drugs are similar in these treatment options, differences are seen in clinical effects and toxicity. Therefore, early determination of adverse effects that are associated with treatment and direction of treatment will improve patient's quality of life and unnecessary dose reduction won't occur.

Anahtar Kelimeler

Ayrıntılar

Birincil Dil

İngilizce

Konular

-

Bölüm

-

Yazarlar

Nilüfer Avcı Bu kişi benim

Osman Manavoğlu Bu kişi benim

Yayımlanma Tarihi

1 Eylül 2011

Gönderilme Tarihi

1 Eylül 2011

Kabul Tarihi

-

Yayımlandığı Sayı

Yıl 2011 Cilt: 37 Sayı: 3

Kaynak Göster

APA
Avcı, N., & Manavoğlu, O. (2011). How To Use Targeted Drugs in Metastatic Renal Cell Cancer. Journal of Uludağ University Medical Faculty, 37(3), 165-168. https://izlik.org/JA62JC44WJ
AMA
1.Avcı N, Manavoğlu O. How To Use Targeted Drugs in Metastatic Renal Cell Cancer. Uludağ Tıp Derg. 2011;37(3):165-168. https://izlik.org/JA62JC44WJ
Chicago
Avcı, Nilüfer, ve Osman Manavoğlu. 2011. “How To Use Targeted Drugs in Metastatic Renal Cell Cancer”. Journal of Uludağ University Medical Faculty 37 (3): 165-68. https://izlik.org/JA62JC44WJ.
EndNote
Avcı N, Manavoğlu O (01 Eylül 2011) How To Use Targeted Drugs in Metastatic Renal Cell Cancer. Journal of Uludağ University Medical Faculty 37 3 165–168.
IEEE
[1]N. Avcı ve O. Manavoğlu, “How To Use Targeted Drugs in Metastatic Renal Cell Cancer”, Uludağ Tıp Derg, c. 37, sy 3, ss. 165–168, Eyl. 2011, [çevrimiçi]. Erişim adresi: https://izlik.org/JA62JC44WJ
ISNAD
Avcı, Nilüfer - Manavoğlu, Osman. “How To Use Targeted Drugs in Metastatic Renal Cell Cancer”. Journal of Uludağ University Medical Faculty 37/3 (01 Eylül 2011): 165-168. https://izlik.org/JA62JC44WJ.
JAMA
1.Avcı N, Manavoğlu O. How To Use Targeted Drugs in Metastatic Renal Cell Cancer. Uludağ Tıp Derg. 2011;37:165–168.
MLA
Avcı, Nilüfer, ve Osman Manavoğlu. “How To Use Targeted Drugs in Metastatic Renal Cell Cancer”. Journal of Uludağ University Medical Faculty, c. 37, sy 3, Eylül 2011, ss. 165-8, https://izlik.org/JA62JC44WJ.
Vancouver
1.Nilüfer Avcı, Osman Manavoğlu. How To Use Targeted Drugs in Metastatic Renal Cell Cancer. Uludağ Tıp Derg [Internet]. 01 Eylül 2011;37(3):165-8. Erişim adresi: https://izlik.org/JA62JC44WJ

ISSN: 1300-414X, e-ISSN: 2645-9027

Uludağ Üniversitesi Tıp Fakültesi Dergisi "Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License" ile lisanslanmaktadır.


Creative Commons License
Journal of Uludag University Medical Faculty is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

2023